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Summary
The impact of many microorganisms on their environ-
ment depends upon their ability to form surface
bound communities called biofilms [1]. Biofilm forma-
tion on implanted medical devices has severe conse-
quences for human health by providing both a portal
of entry and a sanctuary for invasive bacterial and
fungal pathogens [1, 2]. Biofilm regulators and adher-
ence molecules are extensively defined for many bac-
terial pathogens [3–5], but not for fungal pathogens
such as Candida albicans. Elongated filaments called
hyphae are a prominent feature of C. albicans bio-
films, and known genes that promote biofilm forma-
tion are required for hyphal development [2, 6–8].
From a new library of transcription-factor mutants, we
identify Bcr1p, a zinc finger protein required for for-
mation of biofilms but not hyphae. Expression analy-
sis shows that Bcr1p activates cell-surface protein
and adhesin genes, including several induced during
hyphal development. BCR1 expression depends upon
the hyphal regulator Tec1p. Thus, BCR1 is a down-
stream component of the hyphal regulatory network
that couples expression of cell-surface genes to hy-
phal differentiation. Our results indicate that hyphal
cells are specialized to present adherence molecules
that support biofilm integrity.
Results and Discussion
The major fungal pathogen that colonizes medical im-
plants is Candida albicans, causing device-associated
infections with exceptionally high mortality [2, 6, 7].
C. albicans biofilms, like those of many bacteria, arise
from microcolonies that become embedded in an extra-
cellular matrix [4, 7, 9, 10]. Maturation coincides with
increasingly prominent hyphal filaments that extend
biofilm depth. Hyphae engage in interactions that are
lethal to macrophages and endothelial cells [11, 12],
and their presence at the biofilm surface may assist in
evasion of host defenses.
The hyphal development pathway is critical for for-
mation of significant biofilm mass, as indicated by two
lines of evidence. First, mutants defective in the tran-
scription factor Efg1p, a major activator of hyphal de-
velopment, fail to form even a monolayer of cells on
polystyrene [8]. This biofilm defect may arise from al-*Correspondence: apm4@columbia.edutered surface-protein composition and adherence prop-
erties of the efg1/efg1 mutant [13]. Second, the quo-
rum-sensing molecule farnesol, an inhibitor of hyphal
development, also inhibits biofilm formation [14, 15].
C. albicans hyphal development is thus essential for
biofilm formation, although the basis for this require-
ment has not been established.
We have implemented a survey of transcription-
factor function as a strategy to define new critical steps
and gene functions in C. albicans biofilm formation.
Transcription factors play pivotal roles in numerous de-
velopmental pathways, and their potential to control
expression of functionally related or redundant genes
makes them a valuable starting point for analysis of bi-
ological processes. Homology and domain analyses
identified 313 genes that specify putative sequence-
specific DNA binding proteins. We used a split-marker
transposon insertion strategy [16, 17] to disrupt both
alleles of putative transcription-factor genes. Among 99
such genes analyzed thus far (see the Supplemental
Data available with this article online), 16 failed to yield
homozygous mutants, a suggestion that these tran-
scription factors may be essential under our selection
conditions. Viable homozygous mutants were created
with insertions in the remaining 83 transcription-factor
genes.
The mutants were tested for ability to form biofilms
[18]. The wild-type reference strain produced a biofilm
with typical bilayer architecture [7, 10]. Round yeast
cells were found primarily in the basal layer, which ex-
tended up to 80 m (Figures 1A–1D). Hyphae were
found beyond the basal layer at distances of 80–450
m from the substrate (Figures 1A and 1D–1J). The bio-
film caused the substrate to appear opaque to the eye
rather than translucent (Supplemental Data). Cell
growth was mainly confined to the biofilm, such that
the surrounding medium had little turbidity (Supplemental
Data). Strains with insertions in TEC1 (orf19.5908; [19])
and BCR1 (orf19.8342; Biofilm and Cell Wall Regulator)
were defective in biofilm formation.
Tec1p is a TEA/ATTS transcription factor that is re-
quired for hyphal formation [19]. The tec1/tec1 insertion
mutant grew largely as free-living cells in our biofilm-
formation assay, yielding a relatively translucent sub-
strate and turbid medium (Supplemental Data). The ru-
dimentary biofilm produced by the tec1/tec1 strain was
less than 20 m deep (Figure 2G) and composed exclu-
sively of yeast cells (Figure 2B). In contrast, the TEC1/
TEC1 reference strain, analyzed in parallel, produced a
biofilm 250–450 m deep that included many hyphal
filaments (Figures 2A and 2F). The mutant defects were
complemented by an ectopic copy of the wild-type
TEC1 gene (Figures 2C and 2H), thus indicating that
the tec1 insertion mutation is the cause of the biofilm-
formation defect. The biofilm defects of the tec1/tec1
mutant are expected for a strain that is defective in hy-
phal development [8].
Bcr1p is a previously uncharacterized C2H2 zinc fin-
ger transcription factor. It has 56% identity to its S. cere-
visiae homolog, Ypl230Wp (Usv1p), over the 79 amino
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1151Figure 1. Reference Strain Biofilm Archi-
tecture
Biofilms of strain DAY185 were stained with
concanavalin A Alexa Fluor 594 conjugate
(conA) for CSLM visualization.
(A) Assembled side view. The silicone sub-
strate is at the top of the image.
(B–J) Individual slices taken 6–450 m away
from the silicone. The scale bars represent
50 m.acid zinc finger region and no significant homology in
the 662 flanking residues. A bcr1D/bcr1D mutant, like
the original bcr1/bcr1 insertion mutant (data not shown),
produced a rudimentary biofilm less than 20 m deep
(Figure 2I) that included yeast cells interspersed with a
few hyphal filaments (Figure 2D). The overall cell den-
sity of rudimentary biofilms of bcr1/bcr1 strains ap-
peared to be lower than that of the tec1/tec1 strain (Fig-
ures 2B and 2D). The biofilm-formation defect of the
bcr1D/bcr1D strain was reversed by an ectopic copy of
wild-type BCR1 (Figures 2E and 2J). Therefore, Bcr1p
is required for biofilm formation.
We considered the possibility that Bcr1p is required
for hyphal development and that the mutant defect in
biofilm formation might be a consequence of a defect
in hyphal formation. However, BCR1/BCR1 and bcr1D/
bcr1D strains produced hyphae to comparable extents
in several hyphae-inducing media (Supplemental Data).
In addition, under biofilm culture conditions, we ob-
served numerous bcr1D/bcr1D hyphae, along with
yeast cells, suspended in the growth medium (Supple-
mental Data). These observations indicate that Bcr1p
is not required for hyphal formation under free-living
cell growth conditions.
If the bcr1/bcr1 mutant forms hyphae of normal ap-
pearance under free-living growth conditions, why is it
defective in biofilm formation? One possibility is that
the bcr1/bcr1 mutant is unable to form extensive hy-
phae specifically under biofilm growth conditions. A
second is that the bcr1/bcr1 mutant is able to form hy-
phal structures in a biofilm, but these hyphae are func-
tionally defective. To assay hyphal development in the
context of a biofilm, we determined whether incorpora-
tion of bcr1D/bcr1D cells into a mixed biofilm with wild-
type cells permits the mutant to produce hyphae. We
used a green fluorescent protein (GFP) reporter gene in
order to follow the behavior of mutant cells in mixed
biofilms. Integration of the reporter gene did not alter
the biofilm-formation defect of either tec1/tec1 or bcr1D/bcr1D strains (Figures 3D–3F and 3J–3L). A control mix-
ture of a GFP-negative wild-type strain and a GFP-
expressing wild-type strain yielded a biofilm with the
GFP signal clearly detectable in the hyphal layer (Fig-
ures 3A–3C). A control mixture of a GFP-negative wild-
type strain with a GFP-expressing tec1/tec1 insertion
mutant yielded a biofilm devoid of GFP among the hy-
phae (Figures 3G–3I). A mixture of the GFP-negative
wild-type strain with the GFP-expressing bcr1D/bcr1D
mutant yielded a mixed biofilm with numerous hyphae
expressing GFP (Figures 3M–3O). These results indi-
cate that the bcr1D/bcr1D mutant cells can form hy-
phae in the context of a biofilm. The cell-free medium
surrounding a wild-type biofilm did not induce biofilm
formation of the bcr1D/bcr1D mutant (data not shown),
suggesting that contact between wild-type and mutant
cells is required to incorporate mutant hyphae into a
biofilm. We infer that the bcr1D/bcr1D hyphae are func-
tionally defective.
To elucidate the nature of the bcr1D/bcr1D defect,
we analyzed microarray gene-expression comparisons
of mutant (bcr1D/bcr1D) and complemented (bcr1D/
bcr1D+pBCR1) strains, grown as free-living cells in bio-
film-inducing medium (Supplemental Data). Several
findings were verified by Northern or RT-PCR analysis
(Figures 4A and 4B). Among the 22 genes whose ex-
pression is most severely altered in the bcr1D/bcr1D
mutant, 11 specify either cell-surface proteins or cell
wall modification enzymes. In particular, we note the
altered expression of several GPI-linked cell wall pro-
tein genes in the bcr1D/bcr1D mutant, for example
HYR1, ECE1, RBT5, ECM331, and adhesins HWP1 and
ALS3 (Figures 4A and 4B). Therefore, Bcr1p is required
for normal expression levels of several genes that gov-
ern cell-surface properties.
ALS3, which was expressed at 16-fold-lower levels in
the bcr1D/bcr1Dmutant than in the reconstituted strain
(Figure 4B), belongs to the C. albicans ALS adhesin
gene family [6, 20–22]. ALS1 and ALS9 were expressed
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1152Figure 2. Biofilm Production by Wild-Type, Mutant, and Reconstituted Strains
Silicone was incubated under standard conditions (60 hr, 37°C, Spider medium) with C. albicans strains indicated.
(A–E) CSLM biofilm depth views. Biofilms were stained with conA for CSLM visualization, and false-color depth views were constructed, in
which blue color represents cells closest to the silicone and red color represents cells farthest from the silicone. For the reference strain
DAY185 (A), blue = 0 m and red = 700 m; for the tec1/tec1 strain CJN896 (B), blue = 0 m and red = 35 m; for the complemented tec1/
tec1 + pTEC1 strain CJN1023 (C), blue = 0 m and red = 450 m; for the bcr1/bcr1 strain CJN702 (D), blue = 0 m and red = 35 m; for
the complemented bcr1/bcr1 + pBCR1 strain CJN698 (E), blue = 0 m and red = 500 m from the silicone.
(F–J) CSLM side views. Biofilms were stained with conA for CSLM visualization, and side views were constructed. The scale bars represent
50 m (F, H, and J) or 20 m (G and I).at 2-fold-lower levels in the bcr1D/bcr1D mutant, o
swhereas ALS2, ALS4, ALS5, and ALS6 were unaffected,
on the basis of RT-PCR assays (data not shown). Thus, b
wBcr1p is required for full expression of a subset of
ALS genes. t
sThese findings complement the characterization of
C. albicans biofilms through gene-expression analysis. d
BElevated expression of HWP1 and the ALS gene family,
especially ALS1, is characteristic of biofilm cells, in c
tcomparison to free-living cells [10, 13, 23, 24]. Our ob-
servations highlight Hwp1p as a potentially significant m
biofilm adhesin and argue that Als3p, rather than Als1p,
may have a pivotal role. On the other hand, HYR1 ex- m
tpression is reduced in mature biofilm cells [13], and re-
sults for RBT5, CHT2, ECE1, and ECM331 have not p
cbeen reported. Altered expression of these genes in the
bcr1D/bcr1D mutant makes them candidates for medi- p
sators of cell-cell interactions early in biofilm formation.
Several Bcr1p-dependent genes are expressed pref- u
eerentially during hyphal differentiation, for example
HWP1, HYR1, ECE1, RBT5, and ALS3 [25–28]. These m
pobservations suggest that Bcr1p may act downstreamf hyphal developmental regulators to activate expres-
ion of a subset of hyphal-specific genes. As predicted
y this hypothesis, we observed that BCR1 RNA levels
ere reduced approximately 4-fold in the tec1/tec1mu-
ant, in comparison to the wild-type and complemented
trains (Figure 4C). Therefore, BCR1 expression is un-
er positive control by the hyphal regulator Tec1p, and
cr1p, in turn, positively regulates several hyphal-spe-
ific genes. These results support our hypothesis that
he bcr1D/bcr1Dmutant hyphae are functionally abnor-
al in the context of a biofilm.
Hyphae are a prominent feature of C. albicans in
any different contexts, and analysis of nonfilamen-
ous strains has underscored the critical roles that hy-
hae play in C. albicans biology. However, it has been
hallenging to dissect the contributions of hyphal mor-
hology from the associated program of gene expres-
ion. The bcr1D/bcr1D mutant separates the ability to
ndergo hyphal morphogenesis from expression of sev-
ral hyphal-specific genes. Failure of the bcr1D/bcr1D
utant to create a biofilm indicates that part of the hy-
hal gene-expression program is critical for biofilm de-
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1153Figure 3. Mixed Biofilms
Biofilms were formed under standard condi-
tions from a mixed culture of reference strain
DAY185 with the GFP-tagged reference
strain MLR62 (A–C), a single culture of the
GFP-tagged tec1/tec1 mutant strain CJN823
(D–F), a mixed culture of the reference strain
DAY185 with the GFP-tagged tec1/tec1 mu-
tant strain CJN823 (G–I), a single culture of
the GFP-tagged bcr1D/bcr1D mutant strain
CJN750 (J–L), or a mixed culture of the refer-
ence strain DAY185 with the GFP-tagged
bcr1D/bcr1D mutant strain CJN750 (M–O).
Biofilms were stained with conA for CSLM vi-
sualization, and side views were constructed
to show GFP expression, conA staining, or
both, as indicated above each column. The
scale bars represent 50 m (A–C, G–I, and
M–O) or 20 m (D–F and J–L).velopment. The prominence of hyphal surface-protein
genes among Bcr1p targets argues that the unique hy-
phal cell surface promotes biofilm formation.
Supplemental Data
Detailed Experimental Procedures, as well as several supplemen-
tal figures and tables, are available online at http://www.current-
biology.com/cgi/content/full/15/12/1150/DC1/.
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